Skip to content

Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)

IRONY: lIfe afteR ONcoplastic surgerY

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05842148
Acronym
IRONY
Enrollment
250
Registered
2023-05-03
Start date
2023-03-25
Completion date
2025-12-31
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Oncoplastic Breast Surgery, Therapeutic Mammoplasty, Chest Wall Perforated Flaps, Quality of Life

Brief summary

Evaluation of quality of life after conservative oncoplastic surgery in patients with breast cancer

Detailed description

The aim of the study is the evaluation of the oncological, aesthetic and functional results after conservative oncoplastic breast surgery using unilateral or bilateral remodeling techniques in a prospective sample of 250 patients. Endpoints: * evaluation of post-surgical histopathological data with a selective focus on the achievement of oncological radicality in relation to the surgical technique ( resection volume, locoregional extension / TNM / multifocality and tumor biological profile) and any major , minor, delayed associated complications (dehiscence, liponecrosis, infection, seroma, hematoma, fibrosis, scar hypertrophy).This data will be collected through the compilation of a database by the health personnel. * evaluation of aesthetic and functional results related to the quality of life after oncoplastic conservative surgery (unilateral or bilateral), as data perceived by the surgeon (technical analysis), and by the patient (psychosocial well-being, physical discomfort, adverse effects of radiotherapy). This data will be collected through the administration of a questionnaire whose data will be entered into the database by the healthcare personnel.

Interventions

OTHERStudy and recording of post-surgical clinical and pathological data of patients diagnosed with breast cancer undergoing unilateral or bilateral conservative oncoplastic surgery.

Control and review of pathological parameters (oncological radicality resection volume, locoregional extension / TNM / multifocality and tumor biological profile).

OTHERStudy and recording of any associated post-surgical complications (of patients diagnosed with breast cancer undergoing unilateral or bilateral conservative oncoplastic surgery.

Control and review of post-surgical complications (dehiscence, liponecrosis, infection, seroma, hematoma, fibrosis, scar hypertrophy).

OTHERStudy and recording of aesthetic and functional post-surgical results related to the quality of life, as data perceived by the surgeon (technical analysis), and by the patient.

Control and review of technical analysis by the surgeon, and of psychosocial well-being, physical discomfort, adverse effects of radiotherapy by the patient collected through the administration of a questionnaire.

Sponsors

Campus Bio-Medico University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of breast cancer * Must be able for conservative oncoplastic surgery with type 1 and 2 procedures who give informed consent to the study.

Exclusion criteria

* Patients who are pregnant or breastfeeding * Patients in emergency situations * Subjects unable to understand and want

Design outcomes

Primary

MeasureTime frameDescription
evaluation of any post-surgical associated complicationsthree yearsfocus on any major , minor, delayed associated complications (dehiscence, liponecrosis, infection, seroma, hematoma, fibrosis, scar hypertrophy).
evaluation of multifocalitythree yearsfocus on the multifocality (yes or no).
evaluation of tumor biological profilethree yearsfocus on the tumor biological profile ( luminal A, luminal B HER2-, luminal B HER2+, HER2+, triple-negative).
evaluation of post-surgical datathree yearsfocus on the achievement of oncological radicality in relation to the surgical technique (yes or no).
evaluation of resection volumesthree yearsfocus on the resection volume in relation to the surgical technique (cm3).
evaluation of post-surgical staging criteriathree yearsfocus on the locoregional extension (TNM staging criteria, American Joint Committee on Cancer, 8th edition)

Secondary

MeasureTime frameDescription
evaluation of post-surgical functional results related to the quality of life after oncoplastic conservative surgery (unilateral or bilateral) through a questionnaire with scores ranging from 1 to 3.three yearsfocus on data perceived by the patient (psychosocial well-being, physical discomfort, adverse effects of radiotherapy).
evaluation of post-surgical aesthetic resultsthree yearsfocus on data perceived by the surgeon (technical analysis) through a questionnaire with scores ranging from 1 to 3.

Countries

Italy

Contacts

Primary ContactPaolo Orsaria, MD, PhD;
p.orsaria@policlinicocampus.it3282492485
Backup ContactPoliclinico Universitario Campus Bio-Medico
comitato.etico@policlinicocampus.it+3906225418812

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026